Madrigal Pharmaceuticals, Inc. (MDGL)
541.97
-4.92
(-0.90%)
USD |
NASDAQ |
Apr 06, 15:24
Madrigal Pharmaceuticals EPS Diluted (Quarterly) : -2.566 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.538 |
| Pfizer Inc. | -0.2898 |
| Eli Lilly & Co. | 7.024 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| PTC Therapeutics, Inc. | -1.673 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.58M |
| Revenue (Quarterly) | 321.08M |
| Total Expenses (Quarterly) | 379.66M |
| Enterprise Value | 11.90B |
| Gross Profit Margin (Quarterly) | 92.26% |
| Profit Margin (Quarterly) | -18.24% |
| Earnings Yield | -2.37% |
| Normalized Earnings Yield | -2.358 |